Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00354510 | Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis | PHASE2 | COMPLETED | 190 | — | — | Mar 1, 2006 | - | Jun 4, 2012 | 13 | Germany, Netherlands |
| Name | Type | Description |
|---|---|---|
| GW842470X cream | DRUG | - |
Inclusion criteria: * Moderate atopic dermatitis patients (IGA=3). * The disease involvement must be \>5% of body surface area. * Female patients of child-bearing potential must use an appropriate method of contraception. Exclusion criteria: * Patients with any active skin disease other than atop...